Optimization of topical curcumin spanlastics for melanoma treatment.


Journal

Pharmaceutical development and technology
ISSN: 1097-9867
Titre abrégé: Pharm Dev Technol
Pays: England
ID NLM: 9610932

Informations de publication

Date de publication:
Jun 2023
Historique:
medline: 22 5 2023
pubmed: 20 4 2023
entrez: 20 04 2023
Statut: ppublish

Résumé

The aim of the study was to enhance curcumin skin permeability through the preparation of spanlastics. Spanlastics were prepared using the ethanol injection technique through a central composite design using Span 60 concentration (X

Identifiants

pubmed: 37078715
doi: 10.1080/10837450.2023.2204926
doi:

Substances chimiques

Drug Carriers 0
Curcumin IT942ZTH98

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

425-439

Auteurs

Soha Ismail (S)

Department of Pharmaceutics, Egyptian Drug Authority (EDA) Formerly Known as National Organization for Drug Control and Research (NODCAR), Giza, Egypt.

Doaa Garhy (D)

Department of Pharmaceutics, Egyptian Drug Authority (EDA) Formerly Known as National Organization for Drug Control and Research (NODCAR), Giza, Egypt.

Howida K Ibrahim (HK)

Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH